Navigation Links
Only 16% of Donations go to New Cancer Treatments in Some Charities. With cureLauncher, 91% of Contributions Go Directly to New Cures for Cancer.

Bloomfield Hills, MI (PRWEB) December 05, 2012

Vernon Hill is a prostate cancer survivor who led the Relay for Life for three years. He helped raise $900,000, but then suddenly quit. In a story on WNCT News 9, Hill said he believed most of the money went to cancer research. He found out the American Cancer Society puts only 16% of its nearly 1 billion dollar income to what he thinks is most important, cancer research.

According to the American Cancer Society’s Annual Report, 16% of its income goes to “support provided to academic institutions and scientists to seek new knowledge about the causes, prevention and cure of cancer”. Is that a high enough percent to cure cancer?

CureLauncher puts as much money as possible directly into new cancer treatments. “Each person can see exactly where their contribution is used and how it makes a difference”, said President, Stephen Goldner, JD, RAC. " lets you see a new breast cancer treatment in development and connect with the dedicated scientists who are saving lives".    

Dr. Lee Roy Morgan is an esteemed cancer research and has been awarded funding by the National Institutes of Health (NIH) for his work. However, government funding cuts to the NIH may prevent Dr. Morgan from advancing his new breast cancer treatment; abbreviated name DM-CHOC-PEN. Contributions on will allow Dr. Morgan to continue developing this cure.

“We are working through the FDA to move this program forward as quickly as possible” said Dr. Morgan. Ninety one percent of all money donated on cureLauncher will be used to make drug supplies for the next clinical trial. “These donations will make a huge difference toward our goal of improving cancer patients’ lives”.

Each person who donates $25 or more to Dr. Morgan’s research can write a personal and confidential email and receive Dr. Morgan's reply.

The timing for cureLauncher’s introduction is critical. The fiscal cliff is calling for funding to the NIH to be cut by $2.5 billion and eliminate 300 research grants through the National Cancer Institute, said the Biotechnology Industry Organization.

“Anyone who’s been affected by cancer knows how important it is to find new ways of fighting it”, said cureLauncher Vice President, David Fuehrer. “I am a two-time cancer survivor and alive today because of advances in the way cancer is treated. Now with cureLauncher, even small donations make a big impact”.    

Get involved. Find. Fund. Cure.

About CureLauncher
CureLauncher is an online community dedicated to funding new cancer treatments. It connects patients to lifesaving medical research and generates support for new cancer treatments in a way never before possible. Advocates of the research interact with each other and leading medical professionals to generate support.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. University of College London Hospitals (UCLH) Selects GEO SCAN Medical as New Standard of Care for the Detection and Treatment of Prostate Cancer
2. Genomic Health Announces Presentation of Six Studies at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium
3. El profesor e investigador mundial líder en cáncer, Paul Workman, se une a The Innovation Debate 2012
4. Prostate Cancer Medical Websites: Friend Or Foe?
5. Cancer Antibodies: Drug Target Atlas and Competitive Outlook
6. On the hunt for rare cancer cells
7. Novel Cancer Immune Therapy Developer Oncos Therapeutics Appoints Experienced Industry Leader Frans Wuite as President and CEO
8. VolitionRxs Preliminary Diagnostic Clinical Trial Results Show High Sensitivity and Specificity for Colon, Breast and Lung Cancers
9. Response Genetics, Inc. to Offer ROS1 Testing for Lung Cancer
10. Lung Cancer Survivors Share Stories of Value of Early Detection and Hope for More Effective Treatments
11. Multimodal Treatment of Peritoneal Metastases Offers Hope for Many Patients With Colorectal Cancer
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... The United States Golf Association ... 2016 USGA Green Section Award. Presented annually since 1961, the USGA Green Section Award ... work with turfgrass. , Clarke, of Iselin, N.J., is an extension specialist ...
(Date:11/24/2015)... Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... New York on Wednesday, December 2 at ... , president and CEO, will provide a corporate overview. ... at 1:00 p.m. ET/10:00 a.m. PT . ... will provide a corporate overview. --> th Annual ...
(Date:11/24/2015)... ... 2015 , ... Copper is an essential micronutrient that all ... copper is also toxic to cells. With a $1.3 million award from the ... a systematic study of copper in the bacteria Pseudomonas aeruginosa (P. aeruginosa), a ...
(Date:11/24/2015)... - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) (the "Company"), ... Toronto Stock Exchange, confirms that as of the date ... that would cause the recent movements in the Company,s ... About Aeterna Zentaris Inc. . ... Zentaris is a specialty biopharmaceutical company engaged in developing ...
Breaking Biology Technology:
(Date:11/9/2015)... , Nov. 09, 2015 ... addition of the "Global Law Enforcement ... offering. --> ) has ... Law Enforcement Biometrics Market 2015-2019" report ... and Markets ( ) has announced ...
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
(Date:10/29/2015)... Daon, a global leader in mobile biometric ... new version of its IdentityX Platform , IdentityX ... have already installed IdentityX v4.0 and are ... FIDO UAF certified server component as an option ... features. These customers include some of the largest and ...
Breaking Biology News(10 mins):